Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic disruption exacerbates intestinal damage during sleep deprivation by abolishing HIF1α-mediated repair. | Cell Rep | 2024 | 39527478 | PubTator, text mining | PubMed |
| Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia. | J Transl Med | 2024 | 39506809 | PubTator, text mining | PubMed |
| Human prolyl hydroxylase domain 2 reacts with O2 and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor α complexes. | Sci Rep | 2024 | 39478091 | PubTator, text mining | PubMed |
| Branched-chain α-ketoacids aerobically activate HIF1α signalling in vascular cells. | Nat Metab | 2024 | 39472756 | PubTator, text mining | PubMed |
| Current views on the role of HIF-2α in the pathogenesis and syndromic presentation of pheochromocytoma and paraganglioma. | Best Pract Res Clin Endocrinol Metab | 2024 | 39426935 | PubTator, text mining | PubMed |
| Sex differences in genotype frequency and the risk of polycythemia associated with rs13419896 and rs2790859 among Tibetan highlanders living in Tsarang, Mustang, Nepal. | J Physiol Anthropol | 2024 | 39407294 | PubTator, text mining | PubMed |
| Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE. | Heliyon | 2024 | 39381253 | PubTator, text mining | PubMed |
| Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities. | Biol Proced Online | 2024 | 39342097 | PubTator, text mining | PubMed |
| Utility of next-generation sequencing in identifying congenital erythrocytosis in patients with idiopathic erythrocytosis. | Front Med (Lausanne) | 2024 | 39309680 | PubTator, text mining | PubMed |
| Oxygen-dependent regulation of F-box proteins in Toxoplasma gondii is mediated by Skp1 glycosylation. | J Biol Chem | 2024 | 39307307 | PubTator, text mining | PubMed |
| Increased susceptibility of human limbal aniridia fibroblasts to oxidative stress. | Exp Eye Res | 2024 | 39303843 | PubTator, text mining | PubMed |
Reply to correspondence by Deora et al. in Human Genomics 18, article no.: 52 (2024): critical insights on "Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severity in Indian population: a novel finding". | Hum Genomics | 2024 | 39267176 | PubTator, text mining | PubMed |
| Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells. | Mol Med Rep | 2024 | 39239747 | PubTator, text mining | PubMed |
| Adipocyte deletion of the oxygen-sensor PHD2 sustains elevated energy expenditure at thermoneutrality. | Nat Commun | 2024 | 39209825 | PubTator, text mining | PubMed |
| Oxygenator assisted dynamic microphysiological culture elucidates the impact of hypoxia on valvular interstitial cell calcification. | J Biol Eng | 2024 | 39180097 | PubTator, text mining | PubMed |
| Gas Tunnel Engineering of Prolyl Hydroxylase Reprograms Hypoxia Signaling in Cells. | Angew Chem Int Ed Engl | 2024 | 39168829 | PubTator, text mining | PubMed |
| Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α. | Am J Physiol Lung Cell Mol Physiol | 2024 | 39159362 | PubTator, text mining | PubMed |
| TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma. | bioRxiv | 2024 | 39149323 | PubTator, text mining | PubMed |
| Caulerpa chemnitzia polysaccharide exerts immunomodulatory activity in macrophages by mediating the succinate/PHD2/HIF-1α/IL-1β pathway. | Int J Biol Macromol | 2024 | 39098690 | PubTator, text mining | PubMed |
| Golgi Protein 73 Promotes Angiogenesis in Hepatocellular Carcinoma. | Research (Wash D C) | 2024 | 39022745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=9